Skip to main content
Alzinova AB logo

Alzinova AB — Investor Relations & Filings

Ticker · ALZ ISIN · SE0007413455 LEI · 549300K3IMVT20EK2S13 ST Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST ALZ

About Alzinova AB

https://www.alzinova.com/

Alzinova AB is a clinical-stage biopharmaceutical company specializing in the development of disease-modifying treatments for Alzheimer's disease. The company's approach is centered on its proprietary AβCC Peptide™ technology, which is used to develop immunotherapies that specifically target neurotoxic amyloid-beta oligomers, a primary cause of the disease. Alzinova's pipeline includes both active and passive immunotherapies. Its lead candidate, ALZ-101, is a therapeutic vaccine in clinical development designed to stimulate the patient's immune system to counteract the disease's progression, addressing a significant unmet medical need.

Recent filings

No filings indexed yet

We are still gathering filings for Alzinova AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.